MADISON, N.J., Nov. 16 /PRNewswire-FirstCall/ -- At a meeting of its Board of Directors held today, Wyeth announced the election of Robert E. Landry, Jr., 42, to the position of Treasurer, Wyeth, effective January 1, 2007.
Mr. Landry began his career at Wyeth Pharmaceuticals in 1988. In 2004, he was appointed Chief Financial Officer of Wyeth Pharmaceuticals in Australia and New Zealand. In 2006, he was promoted to Director, Sales and Marketing, Wyeth Australia. He succeeds Jack O’Connor, who will become Executive Vice President Global Finance and Information Services, Wyeth Consumer Healthcare.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing and marketing of pharmaceuticals, vaccines, biotechnology products and non-prescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
Wyeth
CONTACT: Media, Douglas Petkus, +1-973-660-5218, or Investors, JustinVictoria, +1-973-660-5340, both of Wyeth
Web site: http://www.wyeth.com//
Company News On-Call: http://www.prnewswire.com/comp/044235.html /
